Cite

    Hallie Coltin et al.. “Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real‐world case series.” Pediatric blood & cancer, vol. 69, no. 8, 2022, p. n/a. http://access.bl.uk/ark:/81055/vdc_100158020542.0x000025